Anna Pagonakis

Array ( [id] => 5924285 [patent_doc_number] => 20060241108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Substituted phenoxazines and acridones as inhibitors of AKT' [patent_app_type] => utility [patent_app_number] => 11/367161 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29322 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241108.pdf [firstpage_image] =>[orig_patent_app_number] => 11367161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7988137 [patent_doc_number] => 08076363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Isothiazolone-containing preservative with improved effectiveness' [patent_app_type] => utility [patent_app_number] => 11/885451 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3760 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076363.pdf [firstpage_image] =>[orig_patent_app_number] => 11885451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291038 [patent_doc_number] => 20090023768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'RAPAMYCIN DERIVATIVES FOR TREATING NEUROBLASTOMA' [patent_app_type] => utility [patent_app_number] => 12/280031 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11191 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023768.pdf [firstpage_image] =>[orig_patent_app_number] => 12280031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880524 [patent_doc_number] => 20080153907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Pharmaceutical Composition for the Treatment of Cancer Comprising Lhm-Ra Complex' [patent_app_type] => utility [patent_app_number] => 11/817101 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6150 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153907.pdf [firstpage_image] =>[orig_patent_app_number] => 11817101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416996 [patent_doc_number] => 20090042883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'ANTITUMOR AGENT' [patent_app_type] => utility [patent_app_number] => 11/816736 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13286 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042883.pdf [firstpage_image] =>[orig_patent_app_number] => 11816736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656521 [patent_doc_number] => 20060142257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Male contraceptive formulation comprising norethisterone' [patent_app_type] => utility [patent_app_number] => 11/356012 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7444 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142257.pdf [firstpage_image] =>[orig_patent_app_number] => 11356012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688881 [patent_doc_number] => 20070105817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension' [patent_app_type] => utility [patent_app_number] => 11/356158 [patent_app_country] => US [patent_app_date] => 2006-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3577 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105817.pdf [firstpage_image] =>[orig_patent_app_number] => 11356158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832956 [patent_doc_number] => 20080131503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Stable Pharmaceutical Composition Comprising a Fixed Dose Combination of Fenofibrate and an Hmg-Coa Reductase Inhibitor' [patent_app_type] => utility [patent_app_number] => 10/582410 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9664 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131503.pdf [firstpage_image] =>[orig_patent_app_number] => 10582410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675770 [patent_doc_number] => 20080213399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Combination Therapies Using Hdac Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/815372 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13667 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213399.pdf [firstpage_image] =>[orig_patent_app_number] => 11815372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270372 [patent_doc_number] => 08211875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Local treatment of neurofibromas' [patent_app_type] => utility [patent_app_number] => 11/815443 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11815443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740623 [patent_doc_number] => 20080234276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/815159 [patent_app_country] => US [patent_app_date] => 2006-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20906 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234276.pdf [firstpage_image] =>[orig_patent_app_number] => 11815159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904587 [patent_doc_number] => 20080114001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of Pyrimidylaminobenzamides for the Treatment of Diseases that Respond to Modulation of Tie-2 Kinase Activity' [patent_app_type] => utility [patent_app_number] => 11/815046 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4788 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114001.pdf [firstpage_image] =>[orig_patent_app_number] => 11815046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753280 [patent_doc_number] => 20080161355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents' [patent_app_type] => utility [patent_app_number] => 11/814455 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 85225 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161355.pdf [firstpage_image] =>[orig_patent_app_number] => 11814455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860409 [patent_doc_number] => 20080269259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Regulation of Autophagy and Cell Survival' [patent_app_type] => utility [patent_app_number] => 11/814365 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19652 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269259.pdf [firstpage_image] =>[orig_patent_app_number] => 11814365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753218 [patent_doc_number] => 20080161293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Antitumor Agent' [patent_app_type] => utility [patent_app_number] => 11/814317 [patent_app_country] => US [patent_app_date] => 2006-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5078 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161293.pdf [firstpage_image] =>[orig_patent_app_number] => 11814317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844741 [patent_doc_number] => 20060122273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use for deferiprone' [patent_app_type] => utility [patent_app_number] => 11/331101 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13490 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 61 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122273.pdf [firstpage_image] =>[orig_patent_app_number] => 11331101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705752 [patent_doc_number] => 20060194800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Pteridine derivatives as nitric oxide synthase activators' [patent_app_type] => utility [patent_app_number] => 11/322914 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7130 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194800.pdf [firstpage_image] =>[orig_patent_app_number] => 11322914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247955 [patent_doc_number] => 20070244189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Antioxidant Material, Anti-Deterioration Agent and Food or Beverage' [patent_app_type] => utility [patent_app_number] => 11/578849 [patent_app_country] => US [patent_app_date] => 2005-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11421 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244189.pdf [firstpage_image] =>[orig_patent_app_number] => 11578849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13740 [patent_doc_number] => 07807662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Platinum IV complex inhibitor' [patent_app_type] => utility [patent_app_number] => 11/317516 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 12808 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807662.pdf [firstpage_image] =>[orig_patent_app_number] => 11317516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797906 [patent_doc_number] => 20080009492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Heterocyclic Carbamate Derivatives, Their Manufacture And Use As Pharmaceutical Agents' [patent_app_type] => utility [patent_app_number] => 11/793750 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23021 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009492.pdf [firstpage_image] =>[orig_patent_app_number] => 11793750 [rel_patent_id] =>[rel_patent_doc_number] =>)